The Aim of This Study is to Investigate the Correlation Between the Severity of Glaucoma and Corneal Biomechanics as Well as Anterior Chamber Parameters.
- Disease/Condition
- Glaucoma
- Drug/Device/Intervention
- Observational study
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- Henan Provincial People's Hospital
- Location
- Zhengzhou, China
- Phase
- N/A
- Start date
- Oct 20, 2022
- End date
- Dec 31, 2024
- Enrollment
- 80 participants
IOP,bIOP,ACD,ACW,SSI,VF
The ocular biomechanical differences between the normal control group and primary glaucoma
 patients, including those treated with conventional medication, laser therapy, and surgery,
 were compared. Additionally, an investigation was conducted to explore the relationship
 between anterior chamber parameters, corneal biomechanics, and the severity of glaucoma
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06340061
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06340061 through Pure Global AI's free database. This phase not specified trial is sponsored by Henan Provincial People's Hospital and is currently Recruitment Completed. The study focuses on Glaucoma. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.